发明授权
US07947730B2 Piperidinium and pyrrolidinium derivatives as ligands for the muscarinic M3 receptor
失效
哌啶鎓和吡咯烷鎓衍生物作为毒蕈碱M3受体的配体
- 专利标题： Piperidinium and pyrrolidinium derivatives as ligands for the muscarinic M3 receptor
- 专利标题（中）： 哌啶鎓和吡咯烷鎓衍生物作为毒蕈碱M3受体的配体
-
申请号： US10561366申请日： 2004-06-23
-
公开(公告)号： US07947730B2公开(公告)日： 2011-05-24
- 发明人: Stephen Paul Collingwood , Urs Baettig , Clive McCarthy
- 申请人： Stephen Paul Collingwood , Urs Baettig , Clive McCarthy
- 申请人地址： CH Basel
- 专利权人： Novartis AG
- 当前专利权人： Novartis AG
- 当前专利权人地址： CH Basel
- 代理商 Cozette M McAvoy
- 优先权： GB0314697.4 20030624; GB0327526.0 20031126
- 国际申请： PCT/EP2004/006795 WO 20040623
- 国际公布： WO2005/000815 WO 20050106
- 主分类号： A61K31/40
- IPC分类号： A61K31/40 ; C07D409/14
摘要：
Compounds of formula I in salt or zwitterionic form wherein, wherein R1, R2, R3, R4, R5, J, L and M have the meanings as indicated in the specification, are useful for treating conditions that are mediated by the muscarinic M3 receptor. Pharmaceutical compositions that contain the compounds and a process for preparing the compounds are also described.
公开/授权文献
- US20060287362A1 Organic compounds 公开/授权日：2006-12-21
信息查询
